These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34960728)

  • 21. Charged amino acid residues of human immunodeficiency virus type 1 nucleocapsid p7 protein involved in RNA packaging and infectivity.
    Poon DT; Wu J; Aldovini A
    J Virol; 1996 Oct; 70(10):6607-16. PubMed ID: 8794295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nucleolin and the packaging signal, psi, promote the budding of human immunodeficiency virus type-1 (HIV-1).
    Ueno T; Tokunaga K; Sawa H; Maeda M; Chiba J; Kojima A; Hasegawa H; Shoya Y; Sata T; Kurata T; Takahashi H
    Microbiol Immunol; 2004; 48(2):111-8. PubMed ID: 14978336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging.
    Luo K; Liu B; Xiao Z; Yu Y; Yu X; Gorelick R; Yu XF
    J Virol; 2004 Nov; 78(21):11841-52. PubMed ID: 15479826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct viral determinants for the packaging of human cytidine deaminases APOBEC3G and APOBEC3C.
    Wang T; Zhang W; Tian C; Liu B; Yu Y; Ding L; Spearman P; Yu XF
    Virology; 2008 Jul; 377(1):71-9. PubMed ID: 18495196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subcellular Localization of HIV-1
    Becker JT; Sherer NM
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28053097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of HIV-1 Gag-RNA Interactions in Cells and Virions by CLIP-seq.
    Kutluay SB; Bieniasz PD
    Methods Mol Biol; 2016; 1354():119-31. PubMed ID: 26714708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dimerization domain of HIV-1 viral infectivity factor Vif is required to block virion incorporation of APOBEC3G.
    Miller JH; Presnyak V; Smith HC
    Retrovirology; 2007 Nov; 4():81. PubMed ID: 18036235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.
    Ding SF; Lombardi R; Nazari R; Joshi S
    Front Biosci; 2002 Feb; 7():a15-28. PubMed ID: 11815282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cellular protein lyric interacts with HIV-1 Gag.
    Engeland CE; Oberwinkler H; Schümann M; Krause E; Müller GA; Kräusslich HG
    J Virol; 2011 Dec; 85(24):13322-32. PubMed ID: 21957284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
    BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
    J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A heterologous, high-affinity RNA ligand for human immunodeficiency virus Gag protein has RNA packaging activity.
    Clever JL; Taplitz RA; Lochrie MA; Polisky B; Parslow TG
    J Virol; 2000 Jan; 74(1):541-6. PubMed ID: 10590146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions between HIV-1 Gag and Viral RNA Genome Enhance Virion Assembly.
    Dilley KA; Nikolaitchik OA; Galli A; Burdick RC; Levine L; Li K; Rein A; Pathak VK; Hu WS
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28539452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced infectivity of human immunodeficiency virus type 1 produced in the presence of a truncated Gag protein containing p7 gag and p6 gag.
    Luukkonen BG; Schwartz S
    Arch Virol; 1998; 143(7):1395-403. PubMed ID: 9722882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of the effect of Staufen1 overexpression on the HIV-1 virus production.
    Park SW; Yu KL; Bae JH; Kim GN; Kim HI; You JC
    BMB Rep; 2021 Nov; 54(11):551-556. PubMed ID: 34353428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-1 Gag Recruits Oligomeric Vpr via Two Binding Sites in p6, but Both Mature p6 and Vpr Are Rapidly Lost upon Target Cell Entry.
    Wanaguru M; Bishop KN
    J Virol; 2021 Aug; 95(17):e0055421. PubMed ID: 34106747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-1 Vif inhibits G to A hypermutations catalyzed by virus-encapsidated APOBEC3G to maintain HIV-1 infectivity.
    Wang Y; Kinlock BL; Shao Q; Turner TM; Liu B
    Retrovirology; 2014 Oct; 11():89. PubMed ID: 25304135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incorporation of functional human immunodeficiency virus type 1 integrase into virions independent of the Gag-Pol precursor protein.
    Liu H; Wu X; Xiao H; Conway JA; Kappes JC
    J Virol; 1997 Oct; 71(10):7704-10. PubMed ID: 9311854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ANP32A and ANP32B are key factors in the Rev-dependent CRM1 pathway for nuclear export of HIV-1 unspliced mRNA.
    Wang Y; Zhang H; Na L; Du C; Zhang Z; Zheng YH; Wang X
    J Biol Chem; 2019 Oct; 294(42):15346-15357. PubMed ID: 31444273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteome analysis of the HIV-1 Gag interactome.
    Engeland CE; Brown NP; Börner K; Schümann M; Krause E; Kaderali L; Müller GA; Kräusslich HG
    Virology; 2014 Jul; 460-461():194-206. PubMed ID: 25010285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of mutations in the human immunodeficiency virus type 1 Gag gene on RNA packaging and recombination.
    Nikolaitchik O; Rhodes TD; Ott D; Hu WS
    J Virol; 2006 May; 80(10):4691-7. PubMed ID: 16641262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.